LEMAITRE VASCULAR, INC. (LMAT) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 77.32M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 71.13M USD | Cost of Goods and Services Sold |
| Research and development | 15.41M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77.32M | (m) | $71.13M | $15.41M | (m) | (m) |
| 2026-03-31 | $73.06M | (m) | $70.77M | $14.10M | (m) | (m) |
| 2025-12-31 | $67.91M | $249.60M | $71.06M | $14.14M | (m) | 27.21% |
| 2025-09-30 | $61.93M | (m) | $69.93M | $14.22M | (m) | (m) |
| 2025-06-30 | $54.77M | (m) | $72.48M | $14.91M | (m) | (m) |
| 2025-03-31 | $53.01M | (m) | $70.60M | $15.65M | (m) | (m) |
| 2024-12-31 | $52.26M | $219.86M | $68.96M | $15.65M | (m) | 23.77% |
| 2024-09-30 | $49.61M | $213.03M | $67.45M | $16.38M | (m) | 23.29% |
| 2024-06-30 | $45.64M | $205.62M | $66.41M | $16.95M | (m) | 22.20% |
| 2024-03-31 | $40.71M | $199.89M | $67.06M | $17.18M | (m) | 20.37% |
| 2023-12-31 | $36.71M | $193.48M | $66.44M | $16.97M | (m) | 18.97% |
| 2023-09-30 | $33.47M | (m) | $65.72M | $16.17M | (m) | (m) |
| 2023-06-30 | $30.44M | $177.17M | $63.08M | $15.41M | (m) | 17.18% |
| 2023-03-31 | $26.77M | $169.16M | $59.35M | $14.24M | (m) | 15.83% |
| 2022-12-31 | $26.83M | $161.65M | $56.76M | $13.29M | (m) | 16.60% |
| 2022-09-30 | $28.16M | $160.20M | $55.40M | $13.20M | (m) | 17.58% |
| 2022-06-30 | $31.09M | $159.54M | $54.95M | $12.58M | (m) | 19.48% |
| 2022-03-31 | $36.41M | $158.10M | $54.56M | $11.89M | (m) | 23.03% |
| 2021-12-31 | $36.42M | $154.42M | $53.04M | $11.80M | (m) | 23.59% |
| 2021-09-30 | $37.67M | $152.47M | $52.64M | $11.21M | (m) | 24.71% |
| 2021-06-30 | $38.61M | $150.52M | $52.85M | $10.46M | (m) | 25.65% |
| 2021-03-31 | $32.38M | $134.70M | $46.76M | $9.95M | (m) | 24.04% |
| 2020-12-31 | $28.79M | $129.37M | $44.75M | $10.10M | (m) | 22.25% |
| 2020-09-30 | $24.17M | $121.99M | $41.86M | $9.73M | (m) | 19.81% |
| 2020-06-30 | $20.06M | $114.67M | $37.09M | $9.91M | (m) | 17.49% |
| 2020-03-31 | $21.10M | $119.30M | $38.43M | $10.03M | (m) | 17.69% |
| 2019-12-31 | $21.18M | $117.23M | $37.38M | $9.28M | (m) | 18.07% |
| 2019-09-30 | $23.45M | $115.45M | $36.29M | $9.12M | (m) | 20.31% |
| 2019-06-30 | $22.16M | $110.52M | $34.26M | $8.88M | (m) | 20.05% |
| 2019-03-31 | $27.78M | $108.05M | $33.12M | $8.61M | (m) | 25.71% |
| 2018-12-31 | $28.21M | $105.57M | $31.63M | $8.20M | (m) | 26.72% |
| 2018-09-30 | $27.34M | $103.33M | (m) | $7.43M | (m) | 26.46% |
| 2018-06-30 | $27.78M | $103.99M | (m) | $7.16M | (m) | 26.71% |
| 2018-03-31 | $21.77M | $102.72M | (m) | $6.80M | (m) | 21.20% |
| 2017-12-31 | $21.10M | $100.87M | (m) | $6.64M | (m) | 20.92% |
| 2017-09-30 | $18.69M | $98.00M | (m) | $6.58M | (m) | 19.07% |
| 2017-06-30 | $18.98M | $96.40M | (m) | $6.35M | (m) | 19.69% |
| 2017-03-31 | $17.23M | $93.03M | (m) | $6.35M | (m) | 18.52% |
| 2016-12-31 | $16.34M | $89.15M | (m) | $6.14M | (m) | 18.32% |
| 2016-09-30 | $15.52M | $86.35M | (m) | $6.19M | (m) | 17.97% |
| 2016-06-30 | $13.49M | $82.16M | (m) | $6.08M | (m) | 16.42% |
| 2016-03-31 | $12.50M | $79.66M | (m) | $5.77M | (m) | 15.70% |
| 2015-12-31 | $11.51M | $78.35M | (m) | $5.48M | (m) | 14.69% |
| 2015-09-30 | $11.16M | $76.55M | (m) | $4.99M | (m) | 14.58% |
| 2015-06-30 | $9.69M | $75.03M | (m) | $4.67M | (m) | 12.92% |
| 2015-03-31 | $8.88M | $73.29M | (m) | $4.48M | (m) | 12.12% |
| 2014-12-31 | $6.34M | $71.10M | (m) | $4.67M | (m) | 8.92% |
| 2014-09-30 | $4.77M | $70.33M | (m) | $4.99M | (m) | 6.79% |
| 2014-06-30 | $3.70M | $68.13M | (m) | $5.18M | (m) | 5.43% |
| 2014-03-31 | $3.16M | $65.92M | (m) | $5.31M | (m) | 4.80% |
| 2013-12-31 | $4.52M | $64.55M | (m) | $5.24M | (m) | 7.00% |
| 2013-09-30 | $4.28M | $61.43M | (m) | $5.40M | (m) | 6.96% |
| 2013-06-30 | $4.50M | $59.78M | (m) | $5.36M | (m) | 7.53% |
| 2013-03-31 | $4.51M | $58.19M | (m) | $5.23M | (m) | 7.75% |
| 2012-12-31 | $4.24M | $56.73M | (m) | $5.09M | (m) | 7.47% |
| 2012-09-30 | $4.14M | $55.34M | (m) | $4.67M | (m) | 7.48% |
| 2012-06-30 | $5.13M | $56.26M | (m) | $4.38M | (m) | 9.12% |
| 2012-03-31 | $4.57M | $57.02M | (m) | $4.29M | (m) | 8.02% |
| 2011-12-31 | $3.69M | $57.69M | (m) | $4.42M | (m) | 6.40% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $4.01M | $56.06M | (m) | $5.49M | (m) | 7.16% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $1.95M | $50.91M | (m) | $5.91M | (m) | 3.83% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |